Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial

Clinical article

Jau-Ching Wu M.D.1,2,4,5, Wen-Cheng Huang M.D., Ph.D.1,2,4, Yu-Chun Chen M.D., M.Sc.4,6, Tsung-Hsi Tu M.D.1,2,4, Yun-An Tsai M.D.2,3,4, Shih-Fong Huang M.D.2,3,4, Hsueh-Chen Huang B.S.1,2, and Henrich Cheng M.D., Ph.D.1,2,4,5
View More View Less
  • 1 Department of Neurosurgery and
  • | 2 Center for Neural Regeneration, Neurological Institute, and
  • | 3 Department of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital;
  • | 4 School of Medicine and
  • | 5 Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan; and
  • | 6 Department of Medical Informatics, Heidelberg University, Heidelberg, Germany
Restricted access

Purchase Now

USD  $45.00

Spine - 1 year subscription bundle (Individuals Only)

USD  $376.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

Object

The study aimed to verify the safety and feasibility of applying acidic fibroblast growth factor (aFGF) with fibrin glue in combination with surgical neurolysis for nonacute spinal cord injury.

Methods

This open-label, prospective, uncontrolled human clinical trial recruited 60 patients with spinal cord injuries (30 cervical and 30 thoracolumbar). The mean patient age was 36.5 ± 15.33 (mean ± SD) years, and the male/female ratio was 3:1. The mean time from injury to treatment was 25.7 ± 26.58 months, and the cause of injury included motor vehicle accident (26 patients [43.3%]), fall from a height (17 patients [28.3%]), sports (4 patients [6.7%]), and other (13 patients [21.7%]). Application of aFGF with fibrin glue and duraplasty was performed via laminectomy, and an adjuvant booster of combined aFGF and fibrin glue (2 ml) was given at 3 and 6 months postsurgery via lumbar puncture. Outcome measurements included the American Spinal Injury Association (ASIA) motor scores, sensory scores, impairment scales, and neurological levels. Examination of functional independence measures, visual analog scale, MR imaging, electrophysiological and urodynamic studies, hematology and biochemistry tests, tumor markers, and serum inflammatory cytokines were all conducted. All adverse events were monitored and reported. Exclusions were based on refusal, unrelated adverse events, or failure to participate in the planned rehabilitation.

Results

Forty-nine patients (26 with cervical and 23 with thoracolumbar injuries) completed the 24-month trial. Compared with preoperative conditions, the 24-month postoperative ASIA motor scores improved significantly in the cervical group (from 27.6 ± 15.55 to 37.0 ± 19.93, p < 0.001) and thoracolumbar group (from 56.8 ± 9.21 to 60.7 ± 10.10, p < 0.001). The ASIA sensory scores also demonstrated significant improvement in light touch and pinprick in both groups: from 55.8 ± 24.89 to 59.8 ± 26.47 (p = 0.049) and 56.3 ± 23.36 to 62.3 ± 24.87 (p = 0.003), respectively, in the cervical group and from 75.7 ± 15.65 to 79.2 ± 15.81 (p < 0.001) and 78.2 ± 14.72 to 82.7 ± 16.60 (p < 0.001), respectively, in the thoracolumbar group. At 24-month follow-up, the ASIA impairment scale improved significantly in both groups (30% cervical [p = 0.011] and 30% thoracolumbar [p = 0.003]). There was also significant improvement in neurological level in the cervical (from 5.17 ± 1.60 to 6.27 ± 3.27, p = 0.022) and thoracolumbar (from 18.03 ± 4.19 to 18.67 ± 3.96, p = 0.001) groups. The average sum of motor items in functional independence measure also had significant improvement in both groups (p < 0.05). The walking/wheelchair locomotion subscale showed increased percentages of patients who were ambulatory (from 3.4% to 13.8% and from 17.9% to 35.7% in the cervical and thoracolumbar groups, respectively). There were no related adverse events.

Conclusions

The use of aFGF for spinal cord injury was safe and feasible in the present trial. There were significant improvements in ASIA motor and sensory scale scores, ASIA impairment scales, neurological levels, and functional independence measure at 24 months after treatment. Further large-scale, randomized, and controlled investigations are warranted to evaluate the efficacy and long-term results.

Abbreviations used in this paper:

aFGF = acidic fibroblast growth factor; ASIA = American Spinal Injury Association; SCI = spinal cord injury; VAS = visual analog scale.

Spine - 1 year subscription bundle (Individuals Only)

USD  $376.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1

    Bunge MB: Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 31:262269, 2008

  • 2

    Cheng H, , Almström S, , Giménez-Llort L, , Chang R, , Ove Ogren S, & Hoffer B, et al.: Gait analysis of adult paraplegic rats after spinal cord repair. Exp Neurol 148:544557, 1997

    • Search Google Scholar
    • Export Citation
  • 3

    Cheng H, , Cao Y, & Olson L: Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 273:510513, 1996

    • Search Google Scholar
    • Export Citation
  • 4

    Cheng H, , Liao KK, , Liao SF, , Chuang TY, & Shih YH: Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine (Phila Pa 1976) 29:E284E288, 2004

    • Search Google Scholar
    • Export Citation
  • 5

    Chuang TY, , Huang MC, , Chen KC, , Chang YC, , Yen YS, & Lee LS, et al.: Forelimb muscle activity following nerve graft repair of ventral roots in the rat cervical spinal cord. Life Sci 71:487496, 2002

    • Search Google Scholar
    • Export Citation
  • 6

    Eftekharpour E, , Karimi-Abdolrezaee S, & Fehlings MG: Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 24:3–4 E19, 2008

    • Search Google Scholar
    • Export Citation
  • 7

    Guest JD, , Hesse D, , Schnell L, , Schwab ME, , Bunge MB, & Bunge RP: Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts. J Neurosci Res 50:888905, 1997

    • Search Google Scholar
    • Export Citation
  • 8

    Hashimoto M, , Sagara Y, , Langford D, , Everall IP, , Mallory M, & Everson A, et al.: Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection J Biol Chem 277:3298532991, 2002

    • Search Google Scholar
    • Export Citation
  • 9

    Hsu SP, , Shih YH, , Huang MC, , Chuang TY, , Huang WC, & Wu HM, et al.: Repair of multiple cervical root avulsion with sural nerve graft. Injury 35:896907, 2004

    • Search Google Scholar
    • Export Citation
  • 10

    Huang MC, , Chen KC, , Chuang TY, , Chang WC, , Lee LS, & Huang WC, et al.: Cervical root repair in adult rats after transection: recovery of forelimb motor function. Exp Neurol 180:101109, 2003

    • Search Google Scholar
    • Export Citation
  • 11

    Huang MC, , Lo MJ, , Lin YL, , Chang SE, , Huang WC, & Kuo WC, et al.: Functional recovery after the repair of transected cervical roots in the chronic stage of injury. J Neurotrauma 26:17951804, 2009

    • Search Google Scholar
    • Export Citation
  • 12

    Huang WC, , Kuo WC, , Cherng JH, , Hsu SH, , Chen PR, & Huang SH, et al.: Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun 349:963968, 2006

    • Search Google Scholar
    • Export Citation
  • 13

    Huang WC, , Kuo WC, , Hsu SH, , Cheng CH, , Liu JC, & Cheng H: Gait analysis of spinal cord injured rats after delivery of chondroitinase ABC and adult olfactory mucosa progenitor cell transplantation. Neurosci Lett 472:7984, 2010

    • Search Google Scholar
    • Export Citation
  • 14

    Imamura T, , Oka S, , Tanahashi T, & Okita Y: Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB/c 3T3 and human vascular endothelial cells. Exp Cell Res 215:363372, 1994

    • Search Google Scholar
    • Export Citation
  • 15

    Kadoya K, , Tsukada S, , Lu P, , Coppola G, , Geschwind D, & Filbin MT, et al.: Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron 64:165172, 2009

    • Search Google Scholar
    • Export Citation
  • 16

    Kirshblum S, , Millis S, , McKinley W, & Tulsky D: Late neurologic recovery after traumatic spinal cord injury. Arch Phys Med Rehabil 85:18111817, 2004

    • Search Google Scholar
    • Export Citation
  • 17

    Lee YS, , Hsiao I, & Lin VW: Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats. J Neurotrauma 19:12031216, 2002

    • Search Google Scholar
    • Export Citation
  • 18

    Lee YS, , Lin CY, , Caiozzo VJ, , Robertson RT, , Yu J, & Lin VW: Repair of spinal cord transection and its effects on muscle mass and myosin heavy chain isoform phenotype. J Appl Physiol 103:18081814, 2007

    • Search Google Scholar
    • Export Citation
  • 19

    Lee YS, , Lin CY, , Robertson RT, , Yu J, , Deng X, & Hsiao I, et al.: Re-growth of catecholaminergic fibers and protection of cholinergic spinal cord neurons in spinal repaired rats. Eur J Neurosci 23:693702, 2006

    • Search Google Scholar
    • Export Citation
  • 20

    Lin PH, , Cheng H, , Huang WC, & Chuang TY: Spinal cord implantation with acidic fibroblast growth factor as a treatment for root avulsion in obstetric brachial plexus palsy. J Chin Med Assoc 68:392396, 2005

    • Search Google Scholar
    • Export Citation
  • 21

    Lin PH, , Chuang TY, , Liao KK, , Cheng H, & Shih YS: Functional recovery of chronic complete idiopathic transverse myelitis after administration of neurotrophic factors. Spinal Cord 44:254257, 2006

    • Search Google Scholar
    • Export Citation
  • 22

    Mackay-Sim A, , Féron F, , Cochrane J, , Bassingthwaighte L, , Bayliss C, & Davies W, et al.: Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 131:23762386, 2008

    • Search Google Scholar
    • Export Citation
  • 23

    Małecki J, , Wiedłocha A, , Wesche J, & Olsnes S: Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1. EMBO J 21:44804490, 2002

    • Search Google Scholar
    • Export Citation
  • 24

    Park KK, , Liu K, , Hu Y, , Smith PD, , Wang C, & Cai B, et al.: Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322:963966, 2008

    • Search Google Scholar
    • Export Citation
  • 25

    Rihn JA, , Anderson DT, , Sasso RC, , Zdeblick TA, , Lenke LG, & Harris MB, et al.: Emergency evaluation, imaging, and classification of thoracolumbar injuries. Instr Course Lect 58:619628, 2009

    • Search Google Scholar
    • Export Citation
  • 26

    Tator CH: Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery 59:957987, 2006

    • Search Google Scholar
    • Export Citation
  • 27

    Tsai EC, , Krassioukov AV, & Tator CH: Corticospinal regeneration into lumbar grey matter correlates with locomotor recovery after complete spinal cord transection and repair with peripheral nerve grafts, fibroblast growth factor 1, fibrin glue, and spinal fusion. J Neuropathol Exp Neurol 64:230244, 2005

    • Search Google Scholar
    • Export Citation
  • 28

    Tsai MC, , Shen LF, , Kuo HS, , Cheng H, & Chak KF: Involvement of acidic fibroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach. Mol Cell Proteomics 7:16681687, 2008

    • Search Google Scholar
    • Export Citation
  • 29

    Tsai PY, , Cheng H, , Huang WC, , Huang MC, , Chiu FY, & Chang YC, et al.: Outcomes of common peroneal nerve lesions after surgical repair with acidic fibroblast growth factor. J Trauma 66:13791384, 2009

    • Search Google Scholar
    • Export Citation
  • 30

    Wu JC, , Huang WC, , Huang MC, , Tsai YA, , Chen YC, & Shih YH, et al.: A novel strategy for repairing preganglionic cervical root avulsion in brachial plexus injury by sural nerve grafting. Clinical article. J Neurosurg 110:775785, 2009

    • Search Google Scholar
    • Export Citation
  • 31

    Wu JC, , Huang WC, , Tsai YA, , Chen YC, & Cheng H: Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary Phase I clinical study. J Neurosurg Spine 8:208214, 2008

    • Search Google Scholar
    • Export Citation
  • 32

    Yang LJ, , Lorenzini I, , Vajn K, , Mountney A, , Schramm LP, & Schnaar RL: Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci U S A 103:1105711062, 2006

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 732 166 36
Full Text Views 162 23 0
PDF Downloads 209 18 0
EPUB Downloads 0 0 0